We are live on ! Find out more
BG

Bahl & Gaynor Portfolio holdings

AUM $19.8B
1-Year Est. Return 19.53%
This Fund
S&P 500
This Quarter Est. Return
+9.49%
1 Year Est. Return
+19.53%
3 Year Est. Return
+63.97%
5 Year Est. Return
+84.2%
10 Year Est. Return
+296.44%
AUM
$18B
AUM Growth
+$1.33B
Cap. Flow
-$21.1M
Cap. Flow %
-0.12%
Top 10 Hldgs %
31.84%
Holding
342
New
16
Increased
129
Reduced
153
Closed
4

Top Buys

Rank Stock Value
1
JPM icon
JPMorgan Chase
JPM
+$90.3M
2
DELL icon
Dell
DELL
+$77.6M
3
CME icon
CME Group
CME
+$75.1M
4
GD icon
General Dynamics
GD
+$44.2M
5
PPL
PPL Corp
PPL
+$30.7M

Top Sells

Rank Stock Value
1
RF icon
Regions Financial
RF
+$62.2M
2
AVGO icon
Broadcom
AVGO
+$59.8M
3
ES icon
Eversource Energy
ES
+$36.2M
4
APD icon
Air Products & Chemicals
APD
+$28.1M
5
UNH icon
UnitedHealth
UNH
+$27.1M

Sector Composition

Rank Sector Weight
1 Technology 22.45%
2 Healthcare 14.96%
3 Financials 13.98%
4 Industrials 12.12%
5 Consumer Staples 11.13%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SLP icon
276
Simulations Plus
SLP
$371M
$597K ﹤0.01%
14,500
EPP icon
277
iShares MSCI Pacific ex Japan ETF
EPP
$2.28B
$579K ﹤0.01%
13,530
TSLA icon
278
Tesla
TSLA
$1.3T
$561K ﹤0.01%
3,191
-242
-7% -$47.3K
CFR icon
279
Cullen/Frost Bankers
CFR
$10.2B
$537K ﹤0.01%
4,773
+68
+1% +$7.27K
INTU icon
280
Intuit
INTU
$89B
$527K ﹤0.01%
811
-325
-29% -$207K
MS icon
281
Morgan Stanley
MS
$340B
$522K ﹤0.01%
5,545
+99
+2% +$8.72K
CI icon
282
Cigna
CI
$74.6B
$519K ﹤0.01%
1,430
-109
-7% -$35.9K
COP icon
283
ConocoPhillips
COP
$141B
$515K ﹤0.01%
4,043
+434
+12% +$49.5K
SCHW
284
Charles Schwab
SCHW
$187B
$505K ﹤0.01%
6,976
-59
-0.8% -$3.88K
EW icon
285
Edwards Lifesciences
EW
$51.7B
$487K ﹤0.01%
5,098
-197
-4% -$16.5K
FHN icon
286
First Horizon
FHN
$12.1B
$484K ﹤0.01%
31,406
-1,051
-3% -$15.1K
LKQ icon
287
LKQ Corp
LKQ
$6.29B
$481K ﹤0.01%
9,000
-248
-3% -$12.3K
CGNX icon
288
Cognex
CGNX
$11.3B
$467K ﹤0.01%
11,000
LUV icon
289
Southwest Airlines
LUV
$23B
$464K ﹤0.01%
15,900
IFF icon
290
International Flavors & Fragrances
IFF
$21.9B
$460K ﹤0.01%
5,352
-150
-3% -$12K
SAP icon
291
SAP
SAP
$238B
$460K ﹤0.01%
2,357
-693
-23% -$123K
AXP icon
292
American Express
AXP
$230B
$459K ﹤0.01%
+2,016
New +$418K
VSS icon
293
Vanguard FTSE All-World ex-US Small-Cap Index Fund
VSS
$11.9B
$456K ﹤0.01%
3,906
-3
-0.1% -$340
FIS icon
294
Fidelity National Information Services
FIS
$22.1B
$445K ﹤0.01%
5,994
-3,382
-36% -$220K
MPLX icon
295
MPLX
MPLX
$59.7B
$441K ﹤0.01%
10,600
+1,100
+12% +$42.7K
BNY
296
Bank of New York Mellon
BNY
$107B
$435K ﹤0.01%
7,552
CHRW icon
297
C.H. Robinson
CHRW
$17.5B
$432K ﹤0.01%
5,670
CAH icon
298
Cardinal Health
CAH
$55.4B
$429K ﹤0.01%
+3,835
New +$414K
NFLX icon
299
Netflix
NFLX
$309B
$416K ﹤0.01%
6,850
+660
+11% +$37.2K
LYTS icon
300
LSI Industries
LYTS
$924M
$395K ﹤0.01%
26,121

Similar funds

Bahl & Gaynor's Q1 2024 Portfolio in Review

As of Q1 2024, Bahl & Gaynor held 342 positions worth $18B, up 8% from $16.6B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Bahl & Gaynor's Q1 2024 filing shows 16 new, 129 increased, 153 reduced and 4 closed positions. Its largest new stake was PPL Corp: 1,151,950 shares worth $31.7M. The largest sale was Regions Financial, an estimated $62.2M.

By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 22% a quarter earlier, followed by Healthcare and Financials.

  • Bahl & Gaynor's largest Q1 2024 buy was PPL Corp: 1,151,950 shares worth $31.7M.
  • Bahl & Gaynor added most to JPMorgan Chase in Q1 2024, an estimated $90.3M increase.
  • Bahl & Gaynor's biggest Q1 2024 reduction was Regions Financial, cutting an estimated $62.2M.
  • Bahl & Gaynor fully exited Johnson Controls International in Q1 2024, selling an estimated $23.6M.
  • Bahl & Gaynor's ten largest holdings make up 32% of its $18B portfolio in Q1 2024.
  • Bahl & Gaynor opened 16 new positions and closed 4 in Q1 2024.
  • Bahl & Gaynor's portfolio value rose 8% quarter-over-quarter to $18B.

Based on Bahl & Gaynor's 13F filing for Q1 2024, filed 10 May 2024.